Anthropic halka arzı talep belirsizliği: yatırımcılar üç trilyon değerlemeye nasıl bakıyor?

Kısaca

Üç el yükseldi: Anthropic hisselerini üç trilyon dolarlık değerlemeyle satın almak ister misiniz? Piyasa belirsizliği ve az sayıda duyuru, IPO talebinin gerçekleşmesi konusundaki güveni azaltıyor İlgili şirketler ve yatırımcılar için takip edilecek önemli göstergeler Anthropic ile OpenAI’nin ilerleyişi ve genel IPO talebinin durumu

Ana mesele

Anthropic'in üç trilyon dolarlık değerlemeyle halka arzı yatırımcı talebinde belirsizlik yaratıyor

Ne değişti?

Yatırımcıların talep tepkisi sınırlı kaldı ve 3 el yükseldi; net bir işaret yok

Beni nasıl etkiler?

Okuyucuya, IPO piyasasındaki belirsizliğin yatırım kararlarını nasıl etkileyebileceğini gösterir

Ne oldu?

SF Tech Week sırasında yatırımcılara 3 trilyon dolarlık değerlemeyle satın alma sorusu soruldu; cevap sınırlı kaldı

Neden şimdi?

IPO piyasasında genel belirsizlik sürüyor; bazı adaylar yatırım sermayesinden çekiniyor

Neden önemli?

Büyük değerlemeler, piyasa talebinin nasıl şekilleneceğini gösterecek kritik bir sinyal

Kimler etkileniyor?

• yatırımcılar
• yapısal IPO'lara hazırlanan şirketler
• hukuk ve danışmanlık firmaları

Sektör ve piyasa etkisi

IPO talebindeki belirsizlik, teknoloji ve finans piyasalarında yatırım iştahını etkileyebilir

Riskler

• talepte zayıflama riski
• piyasa koşullarına bağlı olarak değerleme sapmaları
• regülasyon baskıları

Takip edilmesi gerekenler

• Anthropic ve benzeri aday halların halka arz hazırlıkları
• OpenAI ve diğer büyük oyuncuların IPO hareketleri

Haberin tamamı

An audience at SF Tech Week was asked if they would buy Anthropic shares at a $3 trillion valuation.

Only three hands went up.

The room's response reflects the broader uncertainty in this IPO market.

In San Francisco, the signs that Tech Week had arrived were hard to miss. Planes towed banners advertising startups above the city. Inflatable company mascots greeted commuters outside transit stations. And hundreds of people lined up outside Anthropic's Claude Founder House for the chance to get inside.

But a few blocks away, the mood was more measured. On Wednesday night, a crowd gathered in the Dogpatch for the Tech Insider: Growth Mode event, sponsored by Fidelity.

Minutes after interviewing Anthropic investor Matt Murphy onstage, Business Insider chief correspondent Ben Bergman put a question to the room: When Anthropic goes public, would you buy shares at a $3 trillion valuation?

Three hands went up.

How about $1.5 trillion? A few more hands rose.

It was a surprisingly muted response for the company that has become one of the clearest symbols of the artificial-intelligence gold rush . Its long-awaited public offering is expected to test how much of that hype can survive the scrutiny of the public markets.

The IPO market is having a strange year. By dollars raised, it has been one of the biggest on record, propelled by SpaceX's blockbuster debut. The prospect of Anthropic following before year-end could push that figure into the stratosphere. But the headline numbers obscure a far thinner market underneath.

There have been relatively few offerings, and some of the most closely watched candidates have stumbled. Just last week, smart-ring maker Oura pulled its planned IPO at the eleventh hour, pointing to choppy market conditions.

For Heidi Mayon, a partner at the law firm Simpson Thacher, who worked on Oura's planned offering, the delay reflected a wait-and-see attitude she's seeing across the market. She told the room that companies have been reluctant to go public before Anthropic and OpenAI do.

"There's sort of an overarching feeling that there isn't enough public investor capital available until those deals get done," Mayon said. SpaceX showed that may not be true, she added, but few companies want to compete with the model providers for investor attention.

The bigger challenge, she said, is that artificial intelligence has pushed valuations sky-high in the private markets.

Rather than squeeze every possible dollar out of an offering, Mayon said, some companies may be better off pricing their shares more conservatively. That could leave room for a first-day "pop" and the momentum that comes with it.

Jack Cassel, Nasdaq's senior vice president and head of new listings, had a different message for the room: There is still plenty of capital to take companies public, but the bar has changed.

After years of growth at all costs, investors are now looking for "growth with cash efficiencies and discipline," Cassel told the room. They are asking tougher questions about the business models, a company's product plans, and what comes after the stock launch.

That scrutiny may keep consumer and software companies on the sidelines until one or both of the frontier labs go public, he said.

Other corners of the market are still moving. Biotech has produced 22 IPOs this year, he noted, with more expected before the end of the year.

When Anthropic finally goes public, it will be the biggest test yet of whether the artificial-intelligence hype train has the financial horsepower to back it up.

Read the original article on Business Insider

Kaynaklar

• Business Insider